Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):280–288. doi: 10.1097/QAI.0b013e31828a292c

TABLE 1.

Subject Demographics

HIV-1 Infected
(n = 25)
Uninfected Control
(n = 44)
Male sex, n (%) 19 (76) 21 (48)
Median age, n (range) 50 (31–71) 27 (21–60)
BMI, n (range) 23.5 (18.9–43.5) 23.6 (18–32.9)
Race, n (%)
  White 11 (44) 25, (57)
  Black 13 (52) 1 (2)
  Asian 0 (0) 15 (34)
  Other 1 (4) 3 (7)
Ethnicity, n (%)
  Hispanic 11 (44) 3 (7)
  Non-Hispanic 14 (56) 41 (93)
Smoking status
  Current smoker 14 (56) 2 (5.7)
Mean years since HIV-1
  diagnosis, n (range)
9.5 (1–26) N/A
Mean years of effective ART,
  n (range)
6 (0.5–21) N/A
Mean CD4 count, n (range) 630 (181–1124) N/A
Mean CD4 nadir, n (range) 166 (5–422) N/A
Current antiretroviral usage 9 NNRTI based N/A
13 PI based
4 Raltegravir
  based
5 Abacavir
  containing